Skip to main content
EHC
NYSE Life Sciences

Encompass Health Launches $500M Private Senior Note Offering to Refinance Debt, Extend Maturities

feedReported by PR Newswire
Sentiment info
Neutral
Importance info
7
Price
$107.49
Mkt Cap
$10.663B
52W Low
$92.77
52W High
$127.99
Market data snapshot near publication time

summarizeSummary

Encompass Health announced a private offering of $500 million in senior notes maturing in 2034. The company intends to use the proceeds to redeem $400 million of its outstanding 4.500% Senior Notes due 2028 and repay $100 million on its senior secured revolving credit facility. This move represents a proactive capital management strategy to extend debt maturities and reduce short-term credit facility usage, enhancing the company's financial flexibility. While the new interest rate is not disclosed, extending maturities is generally viewed positively. This follows the company's strong Q1 earnings reported earlier this month.

At the time of this announcement, EHC was trading at $107.49 on NYSE in the Life Sciences sector, with a market capitalization of approximately $10.7B. The 52-week trading range was $92.77 to $127.99. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


show_chartPrice Chart

Share this article

Copied!

feed EHC - Latest Insights

EHC
May 14, 2026, 9:07 AM EDT
Source: PR Newswire
Importance Score:
7
EHC
May 01, 2026, 3:28 PM EDT
Filing Type: 10-Q
Importance Score:
8
EHC
Apr 30, 2026, 4:20 PM EDT
Source: Reuters
Importance Score:
7
EHC
Apr 07, 2026, 9:58 AM EDT
Filing Type: DEF 14A
Importance Score:
7
EHC
Mar 10, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
8
EHC
Feb 26, 2026, 2:45 PM EST
Filing Type: 10-K
Importance Score:
8
EHC
Feb 12, 2026, 3:40 PM EST
Filing Type: 4
Importance Score:
7
EHC
Feb 11, 2026, 3:05 PM EST
Filing Type: 144
Importance Score:
7
EHC
Feb 05, 2026, 4:23 PM EST
Filing Type: 8-K
Importance Score:
8